MIPS AB (0RNQ)
London Exchange · UK · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 406.10 |
|---|---|
| 52-week range | 204.80 – 447.50 |
| Return, 1 month / 3 months | +5.9% / +3.8% |
| Return, 1 year / 3 years | +22.3% / +14.5% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 48.2% |
| Worst drawdown (1 year) | -43.5% |
| Average daily value traded | 2.21M SEK |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MIPS AB is a Swedish company that develops brain protection technology for helmets. Its main product is a low-friction layer that sits inside a helmet and allows the head to slide slightly during an impact, which helps reduce rotational forces on the brain. The company licenses this technology to helmet manufacturers, who use it in products for cycling, skiing, motorcycling, equestrian and other sports and safety markets. MIPS is based in Sweden and works with helmet brands around the world.
The shares are listed on the London Exchange in UK under the code 0RNQ, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MIPS AB (0RNQ) trades on the London Exchange in UK. It last closed at SEK 406.10 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,267 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.3% and over the last three months it rose 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 33.3% | ||
| From 52-week high | -8.4% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.8% | ||
| 6-month return | 53.3% | ||
| 12-month return, skipping the last month | 15.5% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.5% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.21M SEK | ||
| Zero-volume days | 5.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +5.9% |
| 3 months | +3.8% |
| 6 months | +53.3% |
| 1 year | +22.3% |
| 3 years | +14.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 387.83 / 304.57 |
|---|---|
| Golden / death cross (60 days) | Golden, 55 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | SEK 2.5000 |
| 8 May 2025 | SEK 6.5000 |
| 8 May 2024 | SEK 6.0000 |
| 11 May 2023 | SEK 5.5000 |
| 6 May 2022 | SEK 5.0000 |
| 7 May 2021 | SEK 3.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.